Showing results (421-430 of 588) with videos related to

Sort By:
Pageof 59
JCO Precision Oncology|February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell CarcinomaBradley A McGregor, Wanling Xie, Elio Adib, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
Molecular Cell|September 24, 2021
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesisJuan F Linares, Xiao Zhang, Anxo Martinez-Ordoñez, et al.
The Prostate|March 3, 2015
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancerRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
European Urology|September 2, 2023
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer ProgressionAlexandros Papachristodoulou, Isabel Heidegger, Renu K Virk, et al.
Plos One|June 22, 2012
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissuesJustin M Craig, Natalie Vena, Shakti Ramkissoon, et al.
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
International Journal of Cancer|July 19, 2019
Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancerDana Hashim, Amparo G Gonzalez-Feliciano, Thomas U Ahearn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2008
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patientsRichard J Flavin, Paul C Smyth, Stephen P Finn, et al.
Pageof 59